Tag: Health Care

Displaying 521 - 540 of 832 results.

In a comment submitted to North Dakota State Senator Richard L. Brown at his request, staff of the Federal Trade Commission’s Office of Policy Planning, Bureau of Economics, and Bureau of Competition stated that House Bill (HB) 1332, which currently is pending in the legislature, might have the...
The order prohibits Preferred Health Services from orchestrating collective agreements and other terms for physician services when negotiating with health insurance plans and other third party payers. According to the complaint these agreements among the physician-hospital...
Under a consent order announced today by the Federal Trade Commission, Preferred Health Services, Inc. (Preferred Health), a physician-hospital organization consisting of more than 100 doctors and the Oconee Memorial Hospital in northwestern South Carolina, has been barred from collectively...
The Federal Trade Commission has released a study on the strength of competition in the sale of prescription contact lenses. Congress required the study under the Fairness to Contact Lens Consumers Act (FCLCA), which was enacted to promote competition in the contact lens market by enhancing...
Commission authorization of the staff to file amicus brief: The Commission has authorized the staff to file a brief as amicus curiae in Teva Pharmaceuticals USA, Inc. v. Pfizer, Inc., Case No. 04-1186 (Fed. Cir.) in support of Teva’s petition for rehearing or rehearing en banc. The case, which was...
In this amicus brief in support of Teva’s combined petition for rehearing and rehearing en banc, the Commission argues that the court erred in affirming the district court’s dismissal of Teva’s complaint in this Hatch-Waxman Act case. The brief argues that the court applied the wrong...
Commission approval of final consent order: Following a public comment period, the Commission has approved a final consent order in the matter concerning Genzyme Corporation and ILEX Oncology, Inc. The Commission vote approving the final consent order was 4-0-1, with Commissioner Pamela Jones...
The Commission has approved a petition for proposed divestiture received from General Electric Company (GE) and related to the FTC decision and order regarding GE’s acquisition of InVision Technologies (InVision). Under the terms of the order, within six months of the execution date the consent...
A consent order allowed Genzyme’s acquisition of ILEX Oncology, Inc., but requires the companies to divest certain assets in the market for solid organ transplant acute therapy drugs. Specifically, Genzyme is required to divest all contractual rights related to ILEX’s Campath®, an...
The Federal Trade Commission today announced that it will conditionally allow Genzyme Corporation’s (Genzyme) proposed $1 billion acquisition of ILEX Oncology, Inc. (Ilex), provided the companies divest overlapping assets in the U.S. market for solid organ transplant (SOT) acute therapy drugs....
In an initial decision filed on November 8, 2004, and announced today, Administrative Law Judge (ALJ) D. Michael Chappell upheld a Federal Trade Commission complaint filed last year against a physicians’ group practicing in Fort Worth, Texas. In the complaint, the FTC alleged the physicians’ group...
Commission approval of final consent orders: Following a public comment period, the Commission has approved a final consent order in the matter concerning the Virginia Board of Funeral Directors and Embalmers. The Commission vote to approve the final consent order and respond to the commenter of...
A consent order settled charges that the White Sands Health Care System refused to deal with health care insurers that resisted the collectively negotiated prices set by its member physicians and nurse anesthetists. The complaint alleged that these practices increased costs for...
A physician-hospital organization (PHO) in New Mexico has agreed to settle Federal Trade Commission charges that it drove up the cost of health care for consumers in the Alamogordo, NM area by jointly fixing prices charged by physicians and by nurse anesthetists to health plans and other payors....
In response to a request from California Assembly Member Greg Aghazarian, FTC staff have commented on a bill (AB 1960) that requires pharmacy benefit managers ("PBMs") to disclose certain information to purchasers and prospective purchasers of their services, as well as to prescribers and...
The Commission authorized staff to file a complaint in federal district court charging that Alpharma, Inc. and Perrigo Company drove up the prices for over-the-counter store-brand children’s liquid ibuprofen through an agreement eliminating competition between the two firms and...
Generic drug manufacturers Alpharma, Inc. and Perrigo Company will give up $6.25 million in illegal profits to settle Federal Trade Commission charges that their agreement to limit competition for over-the-counter (OTC) store-brand children’s liquid ibuprofen drove up prices and violated federal...

Pages